(Q71227487)
Statements
Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC Clinical Screening Group (English)
V Urosevic
P Chollet
A Adenis
J Chauvergne
P Fargeot
H Roche
P Kerbrat
M A Lentz
P Fumoleau